Predictors of response to a low‐FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Background: Diets low in fermentable sugars (low‐FODMAP diets) are increasingly adopted by patients with functional gastrointestinal disorders (FGID), but outcome predictors are unclear. Aim: To identify factors predictive of an efficacious response to a low‐FODMAP diet in FGID patients with fructose or lactose intolerance thereby gaining insights into underlying mechanisms. Methods: Fructose and lactose breath tests were performed in FGID patients to determine intolerance (positive symptom score) and malabsorption (increased hydrogen or methane concentrations). Patients with fructose or lactose intolerance consumed a low‐FODMAP diet and global adequate symptom relief was assessed after 6–8 weeks and correlated with pre‐diet clinical symptoms and breath test results. Results: A total of 81% of 584 patients completing the low‐FODMAP diet achieved adequate relief, without significant differences between FGID subgroups or types of intolerance. Univariate analysis yielded predictive factors in fructose intolerance (chronic diarrhoea and pruritus, peak methane concentrations and fullness during breath tests) and lactose intolerance (peak hydrogen and methane concentrations and flatulence during breath tests). Using multivariate analysis, symptom relief was independently and positively predicted in fructose intolerance by chronic diarrhoea [odds ratio (95% confidence intervals): 2.62 (1.31–5.27), P = 0.007] and peak breath methane concentrations [1.53 (1.02–2.29), P = 0.042], and negatively predicted by chronic nausea [0.33 (0.16–0.67), P = 0.002]. No independent predictive factors emerged for lactose intolerance. Conclusions: Adequate global symptom relief was achieved with a low‐FODMAP diet in a large majority of functional gastrointestinal disorders patients with fructose or lactose intolerance. Independent predictors of a satisfactory dietary outcome were only seen in fructose intolerant patients, and were indicative of changes in intestinal host or microbiome metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chumpitazi, B. P., Cope, J. L., Hollister, E. B., Tsai, C. M., McMeans, A. R., Luna, R. A., Versalovic, J., & Shulman, R. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13286 · Cited by 436
Shepherd, S. J., & Gibson, P. R. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.07.010 · Cited by 408 · cited 4×
“91 Aphthoid oral ulcers 210 (81) 39 (23) 11 (27) 0.”
InfluentialRao, S. S. C., Yu, S., & Fedewa, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13167 · Cited by 343
Müller-Lissner, S. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00027-1 · Cited by 91
Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?
Spencer, M., Chey, W. D., & Eswaran, S. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0031-x · Cited by 34
Cited by
Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
Misselwitz, B., Butter, M., Verbeke, K., & Fox, M. R. (2019) · Gut · doi:10.1136/gutjnl-2019-318404 · Cited by 390
The nutritional and health attributes of kiwifruit: a review
Richardson, D. P., Ansell, J., & Drummond, L. N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1627-z · Cited by 381
Paediatric functional abdominal pain disorders
Thapar, N., Benninga, M. A., Crowell, M. D., Di Lorenzo, C., Mack, I., Nurko, S., Saps, M., Shulman, R. J., Szajewska, H., van Tilburg, M. A. L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00222-5 · Cited by 221
Hammer, H. F., Fox, M. R., Keller, J., Salvatore, S., Basilisco, G., Hammer, J., Lopetuso, L., Benninga, M., Borrelli, O., Dumitrascu, D., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12133 · Cited by 189
Intestinal Absorption of Fructose
Ferraris, R. P., Choe, J.-Y., & Patel, C. R. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051707 · Cited by 180
Rossi, M., Aggio, R., Staudacher, H. M., Lomer, M. C., Lindsay, J. O., Irving, P., Probert, C., & Whelan, K. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.055 · Cited by 122
Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome
Halmos, E. P., & Gibson, P. R. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14650 · Cited by 112
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Kang, G. G., Trevaskis, N. L., Murphy, A. J., & Febbraio, M. A. (2023) · iScience · doi:10.1016/j.isci.2022.105905 · Cited by 94
Impact of diet on symptoms of the irritable bowel syndrome
Spiller, R. (2021) · Nutrients · doi:10.3390/nu13020575 · Cited by 86
“More useful in the clinical setting is the demonstration that chronic diarrhoea and higher peak breath methane concentrations were predictive of response to the LFD in a group of patients who had a positive lactose or fructose breath hydrogen test [99].”
BackgroundDietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions
Tuck, C. J., & Vanner, S. J. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13238 · Cited by 52
Kanikowska, A., Janisz, S., Mańkowska-Wierzbicka, D., Gabryel, M., Dobrowolska, A., & Eder, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247326 · Cited by 5
Metadata
- Authors
- Wilder‐Smith, C. H., Olesen, S. S., Materna, A., & Drewes, A. M.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-02-24
- Volume
- 45
- Issue
- 8
- Pages
- 1094-1106
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2589886432
- Cited by
- 124
- References
- 5
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.